首页 > 最新文献

Kardiochirurgia I Torakochirurgia Polska最新文献

英文 中文
Can artificial intelligence models predict hospital stays following non-small cell lung carcinoma surgery? 人工智能模型能否预测非小细胞肺癌手术后的住院时间?
IF 1.3 Q4 SURGERY Pub Date : 2025-09-30 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.155014
Gizem Özçıbık Işık, Onur S Özçıbık, Tülay Yıldırım, Burcu Kılıç, Ezel Erşen, Mehmet K Kaynak, Akif Turna, Hasan V Kara

Introduction: The hospitalization day after non-small cell lung carcinoma surgery is important in terms of medical, financial, and social aspects.

Aim: Our study aimed to accurately and successfully predict the rate of postoperative hospitalization shorter than 9 days versus longer than 9 days using artificial intelligence algorithms.

Material and methods: The study included 953 patients who underwent surgery for non-small-cell lung carcinoma between 2001 and 2023. The patients' input data consisted of clinical data, laboratory data, respiratory parameters, and radiological and pathological data. The output data included the hospitalization date. We used a fully connected neural network and the k-layer validation method.

Results: The algorithm's training data had a sensitivity value of 90.3%, a positive predictive value of 87.8%, and an accuracy value of 82.6%. The algorithm's F1 1 score was 89.0%, the F1 0 value was 58.3%, and the F1 mean score was 73.6% for the training data. For the test data, the algorithm's sensitivity value was 83.8%, the positive predictive value was 88.6%, and the accuracy value was 78.7%. The F1 1 score was 86.1%, the test F1 0 score was 54.5%, and the F1 average score was 70.3%. The algorithm for the test data created a ROC curve with an area under the curve of 0.82 (AUC = 0.82).

Conclusions: Artificial intelligence algorithms determined the length of hospital stay after non-small cell lung carcinoma surgery with high accuracy and confidence. During the preoperative period, the estimation of hospital stay length will contribute to personalized patient care.

非小细胞肺癌手术后的住院天数在医疗、经济和社会方面都很重要。目的:我们的研究旨在利用人工智能算法准确、成功地预测术后住院时间小于9天和大于9天的比例。材料和方法:该研究包括2001年至2023年间接受非小细胞肺癌手术的953例患者。患者的输入数据包括临床资料、实验室资料、呼吸参数、放射学和病理学资料。输出数据包括住院日期。我们使用了一个完全连接的神经网络和k层验证方法。结果:该算法的训练数据灵敏度值为90.3%,阳性预测值为87.8%,准确率为82.6%。算法对训练数据的F1得分为89.0%,F1 0值为58.3%,F1平均得分为73.6%。对于测试数据,算法的敏感性值为83.8%,阳性预测值为88.6%,准确率值为78.7%。F1 1分为86.1%,测试F1 0分为54.5%,F1平均分为70.3%。该算法对试验数据生成曲线下面积为0.82的ROC曲线(AUC = 0.82)。结论:人工智能算法确定非小细胞肺癌手术后住院时间具有较高的准确性和置信度。在术前,住院时间的估计将有助于个性化的病人护理。
{"title":"Can artificial intelligence models predict hospital stays following non-small cell lung carcinoma surgery?","authors":"Gizem Özçıbık Işık, Onur S Özçıbık, Tülay Yıldırım, Burcu Kılıç, Ezel Erşen, Mehmet K Kaynak, Akif Turna, Hasan V Kara","doi":"10.5114/kitp.2025.155014","DOIUrl":"10.5114/kitp.2025.155014","url":null,"abstract":"<p><strong>Introduction: </strong>The hospitalization day after non-small cell lung carcinoma surgery is important in terms of medical, financial, and social aspects.</p><p><strong>Aim: </strong>Our study aimed to accurately and successfully predict the rate of postoperative hospitalization shorter than 9 days versus longer than 9 days using artificial intelligence algorithms.</p><p><strong>Material and methods: </strong>The study included 953 patients who underwent surgery for non-small-cell lung carcinoma between 2001 and 2023. The patients' input data consisted of clinical data, laboratory data, respiratory parameters, and radiological and pathological data. The output data included the hospitalization date. We used a fully connected neural network and the k-layer validation method.</p><p><strong>Results: </strong>The algorithm's training data had a sensitivity value of 90.3%, a positive predictive value of 87.8%, and an accuracy value of 82.6%. The algorithm's F1 1 score was 89.0%, the F1 0 value was 58.3%, and the F1 mean score was 73.6% for the training data. For the test data, the algorithm's sensitivity value was 83.8%, the positive predictive value was 88.6%, and the accuracy value was 78.7%. The F1 1 score was 86.1%, the test F1 0 score was 54.5%, and the F1 average score was 70.3%. The algorithm for the test data created a ROC curve with an area under the curve of 0.82 (AUC = 0.82).</p><p><strong>Conclusions: </strong>Artificial intelligence algorithms determined the length of hospital stay after non-small cell lung carcinoma surgery with high accuracy and confidence. During the preoperative period, the estimation of hospital stay length will contribute to personalized patient care.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"163-168"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on "The diagnostic value of thoracic ultrasound in thoracic surgery consultations: a new tool in pleural effusion decision-making". 评议“胸外科会诊中胸部超声的诊断价值:胸腔积液决策的新工具”。
IF 1.3 Q4 SURGERY Pub Date : 2025-09-30 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.154834
Çağrı Zorlu
{"title":"Comments on \"The diagnostic value of thoracic ultrasound in thoracic surgery consultations: a new tool in pleural effusion decision-making\".","authors":"Çağrı Zorlu","doi":"10.5114/kitp.2025.154834","DOIUrl":"10.5114/kitp.2025.154834","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"239"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal treatment strategies in generalized lymphatic anomaly with pleural effusion: a case study and literature review. 广泛性淋巴异常伴胸腔积液的多模式治疗策略:一个病例研究和文献复习。
IF 1.3 Q4 SURGERY Pub Date : 2025-09-30 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.154976
Szymon W Tobor, Dariusz Basek, Lidia Hyla-Klekot, Zbigniew Olczak, Tomasz Koszutski
{"title":"Multimodal treatment strategies in generalized lymphatic anomaly with pleural effusion: a case study and literature review.","authors":"Szymon W Tobor, Dariusz Basek, Lidia Hyla-Klekot, Zbigniew Olczak, Tomasz Koszutski","doi":"10.5114/kitp.2025.154976","DOIUrl":"10.5114/kitp.2025.154976","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"216-221"},"PeriodicalIF":1.3,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670232/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary management of acute type A aortic dissection in a pregnant woman with Marfan syndrome. 马凡氏综合征孕妇急性A型主动脉夹层的多学科治疗。
IF 1.3 Q4 SURGERY Pub Date : 2025-09-29 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.154805
Mikołaj Jodłowski, Adam R Kowalówka, Konrad Mendrala, Anna Bednarek, Tomasz Darocha, Ryszard Bachowski, Radoslaw Gocol
{"title":"Multidisciplinary management of acute type A aortic dissection in a pregnant woman with Marfan syndrome.","authors":"Mikołaj Jodłowski, Adam R Kowalówka, Konrad Mendrala, Anna Bednarek, Tomasz Darocha, Ryszard Bachowski, Radoslaw Gocol","doi":"10.5114/kitp.2025.154805","DOIUrl":"10.5114/kitp.2025.154805","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"236-238"},"PeriodicalIF":1.3,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast implant rupture during coronary artery bypass grafting in a transgender woman. 变性妇女冠状动脉旁路移植术中乳房植入物破裂。
IF 1.3 Q4 SURGERY Pub Date : 2025-09-29 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.154795
Osman Fehmi Beyazal, Percin Karakol, Serap Bas, Selman Sadi Cıtak, Yasin Canbaz
{"title":"Breast implant rupture during coronary artery bypass grafting in a transgender woman.","authors":"Osman Fehmi Beyazal, Percin Karakol, Serap Bas, Selman Sadi Cıtak, Yasin Canbaz","doi":"10.5114/kitp.2025.154795","DOIUrl":"10.5114/kitp.2025.154795","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"232-235"},"PeriodicalIF":1.3,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative outcomes of laparoscopic versus robotic esophagectomy: a systematic review and meta-analysis. 腹腔镜与机器人食管切除术的比较结果:一项系统回顾和荟萃分析。
IF 1.3 Q4 SURGERY Pub Date : 2025-06-30 eCollection Date: 2025-09-01 DOI: 10.5114/kitp.2025.152501
Danilo Coco, Silvana Leanza
<p><strong>Introduction: </strong>Esophagectomy is a complex surgical procedure primarily used for the treatment of esophageal malignancies and other esophageal disorders. In recent years, minimally invasive techniques, such as laparoscopic and robotic-assisted esophagectomy, have gained popularity due to their potential to reduce postoperative morbidity and enhance recovery. However, the comparative effectiveness, safety, and long-term outcomes of laparoscopic versus robotic esophagectomy remain unclear.</p><p><strong>Aim: </strong>This study aims to conduct a systematic review and meta-analysis comparing the perioperative and long-term outcomes of laparoscopic and robotic esophagectomy, with a focus on operative time, estimated blood loss, postoperative complications, length of hospital stay, lymph node yield, R0 resection rate, and oncological outcomes.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted across PubMed, Embase, and the Cochrane Library from inception to January 2023. Randomized controlled trials (RCTs) and observational studies comparing laparoscopic and robotic esophagectomy were included. The primary outcomes were operative time, estimated blood loss, and postoperative complications. Secondary outcomes included length of hospital stay, lymph node yield, R0 resection rate, and long-term oncological outcomes. Meta-analyses were performed using random-effects models. Risk of bias was assessed using the Cochrane Risk of Bias tool for RCTs and the Newcastle-Ottawa Scale (NOS) for observational studies. Publication bias was evaluated using Egger's test. Statistical analyses were conducted using Stata version 16.0, with a <i>p</i>-value < 0.05 considered statistically significant.</p><p><strong>Results: </strong>A total of 24 studies (6 RCTs and 18 observational studies) involving 6,972 patients (3,433 robotic and 3,539 laparoscopic esophagectomy cases) were included. Robotic esophagectomy was associated with a longer operative time (mean difference [MD] = 55.52 minutes, 95% CI: 27.55 to 83.49, <i>p</i> < 0.001) but lower estimated blood loss (MD = -103.67 ml, 95% CI: -162.78 to -44.57, <i>p</i> = 0.001) compared to laparoscopic esophagectomy. Postoperative complications (odds ratio [OR] = 0.78, 95% CI: 0.59 to 1.04, <i>p</i> = 0.091) and length of hospital stay (MD = -0.74 days, 95% CI: -1.82 to 0.34, <i>p</i> = 0.181) were comparable between the two techniques. Robotic esophagectomy demonstrated a higher lymph node yield (MD = 2.38, 95% CI: 0.89 to 3.87, <i>p</i> = 0.002) and a higher R0 resection rate (OR = 1.70, 95% CI: 1.26 to 2.30, <i>p</i> < 0.001). Long-term oncological outcomes, including overall survival and disease-free survival, were similar between the two approaches. Egger's test indicated no significant publication bias.</p><p><strong>Conclusions: </strong>This meta-analysis demonstrates that robotic esophagectomy, despite longer operative times, offers advantages in terms of reduced blood
食管切除术是一项复杂的外科手术,主要用于治疗食管恶性肿瘤和其他食管疾病。近年来,微创技术,如腹腔镜和机器人辅助食管切除术,因其降低术后发病率和增强恢复的潜力而受到欢迎。然而,腹腔镜与机器人食管切除术的有效性、安全性和长期结果的比较仍不清楚。目的:本研究旨在对腹腔镜和机器人食管切除术的围手术期和远期预后进行系统回顾和荟萃分析,重点关注手术时间、估计出血量、术后并发症、住院时间、淋巴结清扫率、R0切除率和肿瘤预后。方法:对PubMed、Embase和Cochrane图书馆从成立到2023年1月进行了全面的文献检索。随机对照试验(rct)和观察性研究比较腹腔镜和机器人食管切除术。主要结果是手术时间、估计失血量和术后并发症。次要结局包括住院时间、淋巴结生成量、R0切除率和长期肿瘤预后。采用随机效应模型进行meta分析。对随机对照试验使用Cochrane偏倚风险评估工具,观察性研究使用纽卡斯尔-渥太华量表(NOS)评估偏倚风险。采用Egger’s检验评价发表偏倚。采用Stata version 16.0进行统计学分析,p值< 0.05认为有统计学意义。结果:共纳入24项研究(6项随机对照试验和18项观察性研究),涉及6,972例患者(3,433例机器人食管切除术和3,539例腹腔镜食管切除术)。与腹腔镜食管切除术相比,机器人食管切除术的手术时间更长(平均差[MD] = 55.52分钟,95% CI: 27.55至83.49,p < 0.001),但估计失血量更低(MD = -103.67 ml, 95% CI: -162.78至-44.57,p = 0.001)。术后并发症(优势比[OR] = 0.78, 95% CI: 0.59 ~ 1.04, p = 0.091)和住院时间(MD = -0.74天,95% CI: -1.82 ~ 0.34, p = 0.181)在两种技术之间具有可比性。机器人食管切除术显示出更高的淋巴结清扫率(MD = 2.38, 95% CI: 0.89 ~ 3.87, p = 0.002)和更高的R0切除率(OR = 1.70, 95% CI: 1.26 ~ 2.30, p < 0.001)。两种方法的长期肿瘤预后(包括总生存期和无病生存期)相似。Egger检验未发现显著的发表偏倚。结论:本荟萃分析表明,与腹腔镜食管切除术相比,机器人食管切除术尽管手术时间较长,但在减少失血量、提高淋巴结产出率和提高R0切除率方面具有优势。两种技术均表现出相当的术后并发症发生率、住院时间和长期肿瘤预后。在腹腔镜和机器人食管切除术之间的选择应根据外科医生的专业知识、患者的具体因素和机构资源进行指导。
{"title":"Comparative outcomes of laparoscopic versus robotic esophagectomy: a systematic review and meta-analysis.","authors":"Danilo Coco, Silvana Leanza","doi":"10.5114/kitp.2025.152501","DOIUrl":"10.5114/kitp.2025.152501","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Esophagectomy is a complex surgical procedure primarily used for the treatment of esophageal malignancies and other esophageal disorders. In recent years, minimally invasive techniques, such as laparoscopic and robotic-assisted esophagectomy, have gained popularity due to their potential to reduce postoperative morbidity and enhance recovery. However, the comparative effectiveness, safety, and long-term outcomes of laparoscopic versus robotic esophagectomy remain unclear.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;This study aims to conduct a systematic review and meta-analysis comparing the perioperative and long-term outcomes of laparoscopic and robotic esophagectomy, with a focus on operative time, estimated blood loss, postoperative complications, length of hospital stay, lymph node yield, R0 resection rate, and oncological outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A comprehensive literature search was conducted across PubMed, Embase, and the Cochrane Library from inception to January 2023. Randomized controlled trials (RCTs) and observational studies comparing laparoscopic and robotic esophagectomy were included. The primary outcomes were operative time, estimated blood loss, and postoperative complications. Secondary outcomes included length of hospital stay, lymph node yield, R0 resection rate, and long-term oncological outcomes. Meta-analyses were performed using random-effects models. Risk of bias was assessed using the Cochrane Risk of Bias tool for RCTs and the Newcastle-Ottawa Scale (NOS) for observational studies. Publication bias was evaluated using Egger's test. Statistical analyses were conducted using Stata version 16.0, with a &lt;i&gt;p&lt;/i&gt;-value &lt; 0.05 considered statistically significant.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 24 studies (6 RCTs and 18 observational studies) involving 6,972 patients (3,433 robotic and 3,539 laparoscopic esophagectomy cases) were included. Robotic esophagectomy was associated with a longer operative time (mean difference [MD] = 55.52 minutes, 95% CI: 27.55 to 83.49, &lt;i&gt;p&lt;/i&gt; &lt; 0.001) but lower estimated blood loss (MD = -103.67 ml, 95% CI: -162.78 to -44.57, &lt;i&gt;p&lt;/i&gt; = 0.001) compared to laparoscopic esophagectomy. Postoperative complications (odds ratio [OR] = 0.78, 95% CI: 0.59 to 1.04, &lt;i&gt;p&lt;/i&gt; = 0.091) and length of hospital stay (MD = -0.74 days, 95% CI: -1.82 to 0.34, &lt;i&gt;p&lt;/i&gt; = 0.181) were comparable between the two techniques. Robotic esophagectomy demonstrated a higher lymph node yield (MD = 2.38, 95% CI: 0.89 to 3.87, &lt;i&gt;p&lt;/i&gt; = 0.002) and a higher R0 resection rate (OR = 1.70, 95% CI: 1.26 to 2.30, &lt;i&gt;p&lt;/i&gt; &lt; 0.001). Long-term oncological outcomes, including overall survival and disease-free survival, were similar between the two approaches. Egger's test indicated no significant publication bias.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This meta-analysis demonstrates that robotic esophagectomy, despite longer operative times, offers advantages in terms of reduced blood ","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 3","pages":"199-205"},"PeriodicalIF":1.3,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12670222/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease. 评价红细胞分布宽度与血小板比值及其他实验室标志物在方丹相关肝病分期中的作用。
IF 1.3 Q4 SURGERY Pub Date : 2025-06-25 eCollection Date: 2025-06-01 DOI: 10.5114/kitp.2025.152440
Paweł Skorek, Beata Róg, Natalia Bajorek, Tadeusz Wilkosz, Lidia Tomkiewicz-Pająk

Introduction: Fontan-associated liver disease (FALD) is a common complication in patients with Fontan circulation.

Aim: We aimed to evaluate the red blood cell distribution width-to-platelet ratio (RPR) index as a non-invasive marker for assessing FALD severity, given its reported usefulness in in conditions such as hepatitis.

Material and methods: This retrospective, cross-sectional study included adult Fontan patients. Laboratory tests, liver elastography, and hemodynamic parameters were analyzed.

Results: Fifty-six patients (24 females, 43%; median age 24 years, interquartile range [22-28]) were enrolled. Patients were grouped by liver stiffness (LS) stage: METAVIR ≤ F2 (22 patients, 39%) and > F2 (34 patients, 61%). The RPR index was significantly higher in the > F2 group (0.08 vs. 0.12, p = 0.02), along with FIB-4 (0.68 vs. 1.06) and APRI (0.36 vs. 0.57). RPR correlated positively with liver stiffness (r = 0.27), total bilirubin (r = 0.43), cystatin C (r = 0.36), and creatinine (r = 0.38) but not with NT-proBNP, pulmonary artery pressure, or maximal oxygen consumption. The ROC curve analysis for predicting LS > F2 showed an AUC of 0.74 (95% CI: 0.61-0.87), comparable to FIB-4. Moreover, in the logistic regression model that accounted for age, gender, height, body weight, and systemic chamber morphology, RPR showed a significant association with LS > F2, with an odds ratio indicating a 1.4-fold (95% CI: 1.1-1.7) increase for every 0.01-unit increase in RPR.

Conclusions: The RPR index is a simple, helpful tool for evaluating FALD severity in Fontan patients.

前言:方丹相关性肝病(FALD)是方丹循环患者的常见并发症。目的:我们的目的是评估红细胞分布宽度与血小板比率(RPR)指数作为评估FALD严重程度的非侵入性标志物,鉴于其在肝炎等疾病中的有用性。材料和方法:这项回顾性、横断面研究包括成年Fontan患者。分析了实验室检查、肝弹性图和血流动力学参数。结果:56例患者中,女性24例,占43%;中位年龄24岁,四分位数范围[22-28])。患者按肝僵硬(LS)分期分组:METAVIR≤F2(22例,39%)和> F2(34例,61%)。> F2组RPR指数显著升高(0.08 vs. 0.12, p = 0.02), FIB-4 (0.68 vs. 1.06)和APRI (0.36 vs. 0.57)也显著升高。RPR与肝硬度(r = 0.27)、总胆红素(r = 0.43)、胱抑素C (r = 0.36)和肌酐(r = 0.38)呈正相关,但与NT-proBNP、肺动脉压或最大耗氧量无关。预测LS > F2的ROC曲线分析显示AUC为0.74 (95% CI: 0.61-0.87),与FIB-4相当。此外,在考虑年龄、性别、身高、体重和全身腔室形态的logistic回归模型中,RPR与LS > F2显著相关,比值比显示RPR每增加0.01个单位,增加1.4倍(95% CI: 1.1-1.7)。结论:RPR指数是评价Fontan患者FALD严重程度的一种简单、有效的工具。
{"title":"Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease.","authors":"Paweł Skorek, Beata Róg, Natalia Bajorek, Tadeusz Wilkosz, Lidia Tomkiewicz-Pająk","doi":"10.5114/kitp.2025.152440","DOIUrl":"10.5114/kitp.2025.152440","url":null,"abstract":"<p><strong>Introduction: </strong>Fontan-associated liver disease (FALD) is a common complication in patients with Fontan circulation.</p><p><strong>Aim: </strong>We aimed to evaluate the red blood cell distribution width-to-platelet ratio (RPR) index as a non-invasive marker for assessing FALD severity, given its reported usefulness in in conditions such as hepatitis.</p><p><strong>Material and methods: </strong>This retrospective, cross-sectional study included adult Fontan patients. Laboratory tests, liver elastography, and hemodynamic parameters were analyzed.</p><p><strong>Results: </strong>Fifty-six patients (24 females, 43%; median age 24 years, interquartile range [22-28]) were enrolled. Patients were grouped by liver stiffness (LS) stage: METAVIR ≤ F2 (22 patients, 39%) and > F2 (34 patients, 61%). The RPR index was significantly higher in the > F2 group (0.08 vs. 0.12, <i>p</i> = 0.02), along with FIB-4 (0.68 vs. 1.06) and APRI (0.36 vs. 0.57). RPR correlated positively with liver stiffness (<i>r</i> = 0.27), total bilirubin (<i>r</i> = 0.43), cystatin C (<i>r</i> = 0.36), and creatinine (<i>r</i> = 0.38) but not with NT-proBNP, pulmonary artery pressure, or maximal oxygen consumption. The ROC curve analysis for predicting LS > F2 showed an AUC of 0.74 (95% CI: 0.61-0.87), comparable to FIB-4. Moreover, in the logistic regression model that accounted for age, gender, height, body weight, and systemic chamber morphology, RPR showed a significant association with LS > F2, with an odds ratio indicating a 1.4-fold (95% CI: 1.1-1.7) increase for every 0.01-unit increase in RPR.</p><p><strong>Conclusions: </strong>The RPR index is a simple, helpful tool for evaluating FALD severity in Fontan patients.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 2","pages":"88-93"},"PeriodicalIF":1.3,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant pseudoaneurysm of the inferior wall of the left ventricle presenting as a pulsatile epigastric mass. 左心室下壁巨大的假性动脉瘤表现为脉动性胃上肿块。
IF 1.3 Q4 SURGERY Pub Date : 2025-06-24 eCollection Date: 2025-06-01 DOI: 10.5114/kitp.2025.152325
Ermal Likaj, Laureta Dibra, Saimir Kuci, Marsela Goga, Fjorba Mana, Altin Veshti
{"title":"Giant pseudoaneurysm of the inferior wall of the left ventricle presenting as a pulsatile epigastric mass.","authors":"Ermal Likaj, Laureta Dibra, Saimir Kuci, Marsela Goga, Fjorba Mana, Altin Veshti","doi":"10.5114/kitp.2025.152325","DOIUrl":"10.5114/kitp.2025.152325","url":null,"abstract":"","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 2","pages":"139-141"},"PeriodicalIF":1.3,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288485/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Removal of a broken venous port from the pulmonary artery: a case series. 从肺动脉移除一个破裂的静脉口:一个病例系列。
IF 1.3 Q4 SURGERY Pub Date : 2025-06-24 eCollection Date: 2025-06-01 DOI: 10.5114/kitp.2025.152327
Andrzej Kutarski, Janusz Gozdek, Paweł Stefańczyk, Łukasz Tułecki, Radosław Pietura, Dorota Nowosielecka

The use of venous access ports carries a risk of complications, including catheter fracture with migration of catheter fragments into the pulmonary arteries. Experience in removing broken catheters is limited and there are no special tools. We present 4 cases of catheter removal using the available lassos/lasso catheter and tools designed for transvenous lead extraction and coronary sinus lead implantation via a femoral and subclavian approach. All four procedures were successful and without complications.

使用静脉通道有并发症的风险,包括导管断裂和导管碎片迁移到肺动脉。拔断导尿管的经验有限,也没有特殊的工具。我们报告了4例使用套索/套索导管和经股骨和锁骨下入路经静脉铅提取和冠状动脉窦铅植入工具的导管取出。4例手术均成功,无并发症。
{"title":"Removal of a broken venous port from the pulmonary artery: a case series.","authors":"Andrzej Kutarski, Janusz Gozdek, Paweł Stefańczyk, Łukasz Tułecki, Radosław Pietura, Dorota Nowosielecka","doi":"10.5114/kitp.2025.152327","DOIUrl":"10.5114/kitp.2025.152327","url":null,"abstract":"<p><p>The use of venous access ports carries a risk of complications, including catheter fracture with migration of catheter fragments into the pulmonary arteries. Experience in removing broken catheters is limited and there are no special tools. We present 4 cases of catheter removal using the available lassos/lasso catheter and tools designed for transvenous lead extraction and coronary sinus lead implantation via a femoral and subclavian approach. All four procedures were successful and without complications.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 2","pages":"112-119"},"PeriodicalIF":1.3,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pitfalls in hybrid procedures in newborns with left-sided obstructive lesions and duct-dependent systemic flow: single-center experience. 新生儿左侧梗阻性病变和导管依赖性全身血流混合手术的缺陷:单中心经验。
IF 1.3 Q4 SURGERY Pub Date : 2025-06-24 eCollection Date: 2025-06-01 DOI: 10.5114/kitp.2025.152331
Michał Buczyński, Jacek Kuźma, Gwan Y Lim, Mohamed S Emam, Marek Rączka, Magdalena Zarlenga, Krzysztof Godlewski, Wojciech Mądry, Piotr Kaźmierczak, Karolina Szymczak, Julita Sacharczuk, Mariusz Kuśmierczyk

Introduction: Hybrid procedures encompass surgical and catheter-based interventions aimed at enhancing survival rates and provide alternative treatment options for severely ill patients.

Aim: This is a retrospective study aimed at analyzing hybrid procedures in infants with complex heart defects and duct-dependent systemic circulation at a high risk of cross-clamp circulation based on a single center's experience.

Material and methods: We included 12 infants (7 boys, 5 girls) who were admitted to our department between 2019 and 2024 and who underwent hybrid surgery due to left-sided obstructive lesions.

Results: All neonates presented progressive heart failure and multiple organ dysfunction preceding hybrid procedures. The interventions were performed at a mean age of 8.6 days, with a mean body weight of 3.3 kg. Extracorporeal membrane oxygenation was required postoperatively in 2 patients. Early and late mortality were 8.3% and 16.6%, respectively. Interstage catheterization was performed in 7 patients requiring re-dilation of pulmonary artery bands and in 2 infants with arterial duct stent stenosis. Severe tricuspid regurgitation and progressive right ventricular dysfunction due to inadequate coronary perfusion were reported in 2 patients.

Conclusions: Hybrid procedures are alternative options for infants with complex heart defects, especially when cross-clamp circulation poses high surgical risk. Multiple reinterventions are necessary to maintain stable hemodynamic status and relieve hypoxia or cardiac compromise. Future studies should aim to refine the timing and techniques of these interventions to improve survival and quality of life.

简介:混合手术包括手术和导管干预,旨在提高生存率,并为重症患者提供替代治疗选择。目的:这是一项回顾性研究,旨在分析基于单一中心经验的复杂心脏缺陷和导管依赖性体循环高危婴儿的混合手术。材料和方法:我们纳入了2019年至2024年间因左侧阻塞性病变而接受混合手术的12名婴儿(7男5女)。结果:所有新生儿在混合手术前均出现进行性心力衰竭和多器官功能障碍。这些干预措施在平均年龄8.6天,平均体重3.3 kg时进行。2例患者术后需要体外膜氧合。早期和晚期死亡率分别为8.3%和16.6%。7例需要肺动脉带再扩张的患者和2例动脉导管支架狭窄的婴儿进行了期间置管。报告了2例因冠状动脉灌注不足导致的严重三尖瓣反流和进行性右心室功能障碍。结论:混合手术是复杂心脏缺陷婴儿的替代选择,特别是当交叉钳循环存在高手术风险时。多次再干预是维持血流动力学稳定,缓解缺氧或心脏损害的必要措施。未来的研究应旨在完善这些干预措施的时机和技术,以提高生存率和生活质量。
{"title":"Pitfalls in hybrid procedures in newborns with left-sided obstructive lesions and duct-dependent systemic flow: single-center experience.","authors":"Michał Buczyński, Jacek Kuźma, Gwan Y Lim, Mohamed S Emam, Marek Rączka, Magdalena Zarlenga, Krzysztof Godlewski, Wojciech Mądry, Piotr Kaźmierczak, Karolina Szymczak, Julita Sacharczuk, Mariusz Kuśmierczyk","doi":"10.5114/kitp.2025.152331","DOIUrl":"10.5114/kitp.2025.152331","url":null,"abstract":"<p><strong>Introduction: </strong>Hybrid procedures encompass surgical and catheter-based interventions aimed at enhancing survival rates and provide alternative treatment options for severely ill patients.</p><p><strong>Aim: </strong>This is a retrospective study aimed at analyzing hybrid procedures in infants with complex heart defects and duct-dependent systemic circulation at a high risk of cross-clamp circulation based on a single center's experience.</p><p><strong>Material and methods: </strong>We included 12 infants (7 boys, 5 girls) who were admitted to our department between 2019 and 2024 and who underwent hybrid surgery due to left-sided obstructive lesions.</p><p><strong>Results: </strong>All neonates presented progressive heart failure and multiple organ dysfunction preceding hybrid procedures. The interventions were performed at a mean age of 8.6 days, with a mean body weight of 3.3 kg. Extracorporeal membrane oxygenation was required postoperatively in 2 patients. Early and late mortality were 8.3% and 16.6%, respectively. Interstage catheterization was performed in 7 patients requiring re-dilation of pulmonary artery bands and in 2 infants with arterial duct stent stenosis. Severe tricuspid regurgitation and progressive right ventricular dysfunction due to inadequate coronary perfusion were reported in 2 patients.</p><p><strong>Conclusions: </strong>Hybrid procedures are alternative options for infants with complex heart defects, especially when cross-clamp circulation poses high surgical risk. Multiple reinterventions are necessary to maintain stable hemodynamic status and relieve hypoxia or cardiac compromise. Future studies should aim to refine the timing and techniques of these interventions to improve survival and quality of life.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":"22 2","pages":"79-87"},"PeriodicalIF":1.3,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12288494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144734873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Kardiochirurgia I Torakochirurgia Polska
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1